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Circulating tumor cells (CTCs) from peripheral blood account genetic information for cancer diagnosis and overall disease monitoring. Analysis of “liquid
biopsy” holds immense promise as it may lead to new approaches for cancer
treatment. The study reports effective and continuous flow microchannel
system for isolating CTCs using transferrin conjugated 3D matrix synthesized by crosslinking polyethylene glycol-Fe3O4 nanostructures for rapid and
efficient capturing of CTCs. The platform provides option of using multiple
microchannel units in series that can influence higher cell-capture efficiency
due to increasing cell-substrate contact frequency. CTCs are captured with
high efficiency even at low concentration of target cells (~90% at 25 cells
per mL blood). Furthermore, the study demonstrates that the cell-capture
performance is influenced by topographic interactions between nanostructure
based matrix and cancer cells of interest. In addition, this study demonstrates
the “proof of concept” using 3D microchannel system having capacity of
simultaneously capturing and permanently eliminating CTCs from peripheral
blood samples. Further, the study evaluates clinical samples of colon and
breast cancer patients for rapid isolation of CTCs. Conclusively, the present
platform demonstrates inordinate capacity for cancer cell sorting, biological
studies of CTCs, and cancer metastasis, potentially benefiting the real time
liquid biopsy and early prognosis of cancer.
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1. Introduction

Circulating tumor cells (CTCs) disseminate from the primary tumor and
migrate in peripheral blood of cancer
patients.[1–4] CTCs play an important role
in metastases and are primarily responsible for the growth of secondary tumors
and spread of cancer in distant part of
the body.[5–7] Besides conventional diagnostic approaches (e.g., tumor biopsy,
anatomical/molecular
imaging,
and
serum marker detection), detecting CTCs
in peripheral blood is of prognostic value
to predict disease progression, response
to treatment, relapse, and overall survival.[8–10] However, the detection and
characterization of CTCs have been technically challenging due to their extremely
low occurrence (10–100 mL−1) among a
high number (109 cells mL−1) of hematologic cells in blood.[7,8] In recent years, a
diversity of diagnostic methods have been
developed for CTC detection and enrichment that principally include immunomagnetic separation,[2,11] microfluidic
platforms,[8,12,13] and microfilter devices.[14]
Microfluidic approaches require precise control over operational parameters and often involve complex designs besides
being slow due to lower fluid transfer rates, thus limiting them
in time efficiency and high throughput analysis. On the other
hand, immunomagnetic methods for separation of CTCs are
simple to use but suffer relatively low separation efficiency
and require pretreatment of blood to remove hematogenic
cells.[15] Food and Drug Administration-approved CellSearch
Technology uses markers with immunomagnetic beads to isolate CTCs. To enhance CTC capturing efficiency and to reduce
cost, researchers have been exploring new platforms including
microrockets.[2,5,8,16,17]
Here, we report the use of glass capillary-flow channel functionalized with 3D antibody matrix impinged with magnetic
nanoparticles for simultaneous isolation and detection of CTCs
from clinical samples. Nanostructure materials such as nanopillars, graphene sheets, and nanoparticles enhance biomolecule

© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim

wileyonlinelibrary.com

(1 of 9) 1600934

full paper

Biofunctionalized Capillary Flow Channel Platform
Integrated with 3D Nanostructured Matrix to Capture
Circulating Tumor Cells

www.advancedsciencenews.com

full paper

www.advmatinterfaces.de

Figure 1. Schematic representation of the configuration and operational mechanism of multi-unit microchannel system for capturing circulating tumor
cells (CTCs). a) 3D Fe3O4-GSH-PEG-Tf matrix conjugated microchannel glass substrate with 91 mm of length, 1.55 mm of diameter, and 162 mm3
volume. b) Cancer patient’s blood sample is fed in the first 3D microchannel capillary to capture CTCs. Subsequently, blood with the uncaptured cells
from the first microchannel is then fed to the second microchannel capillary and similarly to the third microchannel capillary. Finally, the CTC capturing
efficiency is calculated using the set of three cycles. Intermediate outlets between microchannels enable cell capture efficiency estimation of individual microchannels. c) Fe3O4-GSH-PEG-Tf matrix conjugated glass capillary image. d) Pseudo-3D electron microscopy images of glass capillary and
e) Fe3O4-GSH-PEG-Tf conjugated glass capillary demonstrating 3D surface on CTC substrate using Zeiss Zen software.

recognition.[18] Most of these CTC capturing platforms are limited by single unit operations. Therefore, we hypothesized that
integrating a flow-channel unit system such as glass capillary
with a patterned 3D matrix based on nanostructured materials
will offer unique advantages such as (i) better cell–substrate
contact frequency leading to enhanced CTC capture due to the
3D matrix and high surface to volume ratio of glass capillary,
(ii) opportunity of using multiple units in series for higher cell
capture efficiency and sensitivity, (iii) user flexibility to adjust
the number of capillary units that best fit his particular assay,
and (iv) also the capillaries with different coatings and targeting
moieties can be applied simultaneously for isolating CTCs
based on specific affinity as well as to sort them as they often
exist with many subtypes by multiple isolation steps. Glassbased materials have been widely accepted in applications such
as cell fixing substrates and as promising biocompatible materials.[19,20] However, the glass-based materials suffer from other
disadvantages such as low cell affinity. To overcome this, most
existing technologies rely on chemical modification to render
the inert surfaces bioactive.[20]
In study we principally employed HCT116 colon cancer cells
overexpressing transferrin-receptors (TfRs) to probe the capture
efficiency of capillary flow-cell platform. Thus advantages of our
platform are: (1) nanoprotrusions generated by Poly(ethylene
1600934 (2 of 9)
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glycol)-iron oxide (PEG-Fe3O4) functionalized “Transferrinconjugated Nanostructured Matrix on Silane-Functionalized
Glass Capillary” (Tf-NMSFGC) increases the topographic
interactions between cancer cells and substrate as depicted
in Figure 1. (2) The dimensions of the platform mediate high
density packing of PEG-Fe3O4-Tf on NMSFGC, which results
in increased local concentration of Tf, and (3) optimized multicomponent 3D matrix with tunable architecture by application
of PEG to cross-link Fe3O4 nanoparticles. The length of the capillary flow channel was 91 mm while the volume was 162 mm3.
These aspects of capillary flow channel 3D system synergistically contribute to enhance capture of cancer cells.

2. Results and Discussion
The 3D nanostructured matrix was synthesized through a
multistep process (Figure 2). First, the cross-linked matrix
of PEG-Fe3O4 was obtained according to our recent procedure.[17] Second, the resulting PEG-Fe3O4 was functionalized
with specific targeting ligand Tf and then chemically immobilized to the amine-functionalized silanated glass through
the reactive carboxyl group of the glutathione (GSH) linker
using N-(3-dimethylaminopropyl)-N-ethylcarbodiimide HCl
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Figure 2. Synthetic scheme of Tf-NMSFGC microchannel system. a) TEM image of the branched structure where multiple Fe3O4 nanoparticles are
cross-linked by PEG chains forming a 3D matrix. b) Optical image of a cross-section of Tf-NMSFGC substrate. The average thickness of the matrix
(shown by a dotted red circle) estimated from the images was 11 ± 1 µm and few isolated aggregates with thickness ~34 ± 1 µm were also present.

(EDC·HCl) coupling reaction. An amide linkage was formed
between the carboxyl group of PEG-Fe3O4 and the amine group
of silane. Finally, the unreacted components on the glass substrate were removed by a series of washings with Milli-Q water.
It was noted that ≈2.0 mg Fe3O4-GSH-PEG-Tf was chemically
deposited on the glass substrate. Consequently, a flow-channel
system with Fe3O4-GSH-PEG-Tf 3D matrix of ≈91 mm long

Adv. Mater. Interfaces 2017, 4, 1600934

chaotic mixing channel (od = 1.82 and id = 1.55 mm) was produced. The amount of amine groups on the silanized glass
surface was estimated to be ≈16 nm−2. The anchoring of the
Fe3O4-GSH-PEG-Tf matrix on the silane-functionalized glass
was found to be strong, as the Tf-NMSFGC platform could survive multiple cycles of washings and drying. Figure 2 (inset)
shows a typical transmission electron microscopy (TEM)
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image of the PEG-Fe3O4 matrix, which confirms the crosslinking of the Fe3O4 nanoparticles through the PEG chains,
thereby leading to 3D nanoscale architecture. The darker parts
in the image result from the Fe3O4 particles as they are more
electron-dense than the PEG chains. The mean size of Fe3O4
nanoparticles in the matrix was estimated to be ≈24 ± 8 nm,
which corroborates well with their starting size. It also suggests
that the conjugation reaction did not alter the morphology of
the particles. Furthermore, the nanosystem was characterized
by Fourier Transform Infrared (FTIR) spectroscopy to verify
successful conjugation of PEG and Tf to Fe3O4-GSH (Figure S1,
Supporting Information). The IR spectrum of Fe3O4-GSH
showed peaks at 1630, 1542, 1390, and 890 cm−1 corresponding
to CN and FeO bonds, respectively. The IR spectrum of
Fe3O4-GSH-PEG and Fe3O4-GSH-PEG-Tf showed additional
peak at 1262 cm−1 due to CO stretch and resulted from the
presence of PEG. The IR spectrum of Fe3O4-GSH-PEG-Tf
showed new peak at 1542 cm−1 confirming conjugation of Tf
with Fe3O4-GSH-PEG.[17]
The flow-channel substrate was evaluated by analyzing the
cross-section of the NMSFGC substrate (Figure 2, inset). The
average thickness of the matrix (shown by the dotted red circle)
was estimated to be ≈11 ± 1 µm from the TEM image. A few
isolated aggregates with thickness ≈34 ± 1 µm were also present. The amount of matrix covering the flow-channel surface
was estimated to be ≈2.0 ± 0.2 mg. Furthermore, the matrix was
found to cover 90% of the surface when evaluated using optical
microscopy and ImageJ software (Figure 3). On the other hand,
the density of Tf on the Tf-NMSFGC matrix was estimated to
be ≈285 mg g−1 by a modified Bradford procedure.
The performance of this integrated flow-channel glass substrate system was evaluated at first using TfR-positive HCT116

Figure 3. Optical microscopy image of microchannel system coated with
Fe3O4-GSH-PEG-Tf matrix (2.0 mg).

cells. As shown in Figure 4, a 15 min incubation using the TfNMSFGC flow-channel system showed excellent cell-capture
efficiency of >95% (Figure 5a). Two control experiments based
on identical design features (1) without Fe3O4-GSH-PEGTf matrix on flow-channel device surface and (2) NMSFGC
without Tf were also evaluated. As shown in Figure 5a, the
flow-channel system without Fe3O4-GSH-PEG-Tf matrix and
NMSFGC showed significantly less cell attachment of 5%
and 52%, respectively. Thus, the (complete) Tf-NMSFGC flowchannel system showed ≈19 times and times higher cancer
cell-capture efficiency as compared with flow-channel systems
without Fe3O4-GSH-PEG-Tf matrix and NMSFGC without Tf,
respectively. The results clearly confirm that the cancer cellcapture efficiency of the system without Fe3O4-GSH-PEG-Tf
matrix was significantly less, suggesting that both Fe3O4-GSHPEG matrix and Tf were crucial for enhanced performance.
The capture efficiency of Tf-NMSFGC was further investigated with increasing order of cell concentrations of 25, 50,
and 100 cells mL−1 (Figure 5b). Tf-NMSFGC was found to

Figure 4. a) Schematic representation of HCT116 cells captured from cell medium on 3D Tf-NMSFGC microchannel system. b,c) Fluorescence images
of HCT116 cells captured from cell medium on 3D Tf-NMSFGC microchannel system after 15 min incubation.
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Figure 6. Images of HCT116 cells captured on Tf-NMSFGC microchannel
system after 24 h. a) 10× magnification and b) 20× magnification.

Figure 5. a) CTC capture efficiency of Fe3O4-GSH-PEG-Tf coated microchannel system in cell medium (n = 3). b) CTC capture efficiency of Fe3O4GSH-PEG-Tf and Fe3O4-GSH-PEG (control) coated microchannel system
in cell medium having different cell concentration (n = 3).

capture 96%, 89%, and 88% cells, respectively, demonstrating
that the cell-capture efficiency showed a similar trend even at
higher cell concentrations. Interestingly, the highest CTC efficiency was achieved with the lower number of cells (i.e., for
25 cells concentration mL−1). This might be due to the optimal
cell number and the optimized available surface area in flowchannel substrate. Furthermore, it was found that the captured
cells remained intact for ≈24 h and could be used for further
studies (Figure 6).
To further investigate the influence of Fe3O4-GSH-PEG-Tf
matrix on cell capture efficiency, the flow-channel system was
functionalized with different amounts of matrix (0.7–2.0 mg
per glass capillary) and then evaluated for capturing HCT116
cancer cells. The study showed that the cell capture efficiency
increased with increasing amount of 3D matrix (Figure 7). The
capture efficiency increased from 48% to 96% when the matrix
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amount increased from 0.7 to 2.0 mg. Thus, the flow-channel
system with higher matrix amount (2.0 mg) showed two fold
increase in capture efficiency for HCT116 cells as compared
to the system with lower amount (0.7 mg). This difference further verified the contribution of the matrix in improving cell
anchorage due to enhanced topographic interactions between
the Fe3O4-GSH-PEG-Tf matrix and the surface of the cancer
cells, leading to the enhanced cell capture.
Furthermore, capability of the flow-channel system to capture rare tumor cells was validated using bio-simulated CTC
samples. The sample was prepared by spiking Green Flurescencent Protein (GFP) labeled HCT116 cells into whole
(human) blood with concentrations of about 25 cells mL−1.
For comparison, capture efficiency was also evaluated in lysed
blood spiked with similar concentrations of HCT116 cells.
After 15 min incubation of the bio-simulated CTC sample in
Tf-NMSFGC flow-channel system, HCT116 cells were found
to be attached to the Fe3O4-GSH-PEG-Tf matrix as shown in
Figure 8a–c. The 3D images of the flow-channel system incubated with spiked blood sample clearly revealed immobilization
of the HCT116 cells on Fe3O4-GSH-PEG-Tf matrix, thus confirming the cell capture due to the presence of nanostructurebased matrix (Figure 8d). The CTC capture efficiency in Red
Blood Cell (RBC) lysed blood was 92%, and in intact peripheral
blood was 88% (Figure 8e), comparable to the capture efficiency
in McCoy medium (96%). It can be observed that Tf-NMSFGC
flow-channel system could efficiently capture HCT116 cells in
all cases. The capture efficiencies were comparable and did not
have significant differences regardless of whether the red blood
cells were lysed or intact. These results clearly suggest that
complex conditions had no significant effects on the cancer cell

Figure 7. Effect of Fe3O4-GSH-PEG-Tf matrix concentration on cell capture efficiency from medium having 25 cells mL−1.
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Figure 8. a–c) Bright field and fluorescent images of HCT116 cells captured from spiked blood on 3D Tf-NMSFGC microchannel system after 15 min
incubation. d) Pseudo-3D image of CTCs captured on Fe3O4-GSH-PEG-Tf coated capillary. e) CTC capture efficiency of Fe3O4-GSH-PEG-Tf coated capillary in whole blood with RBC lysis, without RBC lysis, and in culture media (n = 3).

capturing ability and Tf-NMSFGC flow-channel system can be
directly used in whole blood.
After confirming that the Tf-NMSFGC flow-channel system
with the matrix can rapidly and efficiently capture tumor cells,
we translated the system to study clinical samples from three
cancer patients’ peripheral blood (including colon and breast
cancer patients). As in control, blood was also processed from
healthy individuals. Cells were identified as CTCs when stained
positive for tumor markers cytokeratin (CK18) and DNA interacting probe (4,6-diamidino-2-phenylindole i.e. DAPI) and
negative for leukocyte markers (CD45). The images of CTCs
captured from clinical samples with our method from 0.1 mL
of blood are shown in Figure 9. As shown in the image, CTCs
exhibited strong CK staining and DAPI staining confirming
intact nuclei in the captured cells. Conversely, no CTC was
found in any healthy samples, suggesting that the Tf-NMSFGC
flow-channel system can be successfully applied to real patient
blood samples. We anticipate the capture of CTCs from
cancer patients having anti-epithelial cell adhesion molecules
(EpCAM). Further study in this direction with greater numbers
of clinical samples is currently in progress. Our system exhibited excellent capacity in capturing CTCs as it offers flexibility
of using 3D flow-channel system units in series for cancer cell
capture, which is otherwise not easy to be captured from one
cycle. A continuous microflow-system in controlling the feed
and output using patient’s sample is currently being designed
and evaluated.
1600934 (6 of 9)
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3. Conclusions
We developed a new-generation flow-channel system by synergistically incorporating Fe3O4-GSH-PEG-Tf nanostructured
3D matrix by chemical conjugation. This unique flow-channel
system combines simple flow-channel system with a 3D nanostructured matrix to produce a synergistic effect of enhanced
cell–substrate contact frequency as well as affinity. The resulting
flow-channel system exhibited efficient and rapid (within
15 min) CTC-capturing ability in both cell medium and in
spiked blood samples. Furthermore, the system was successfully
employed for detecting cancer patient’s clinical peripheral blood
samples, endorsing their clinical potential in CTC studies. We
envision that the novel flow-channel will open new opportunities for early diagnosis of cancer metastasis as well as recovery of
other rare cells, proteins, DNA, and from biological specimens.

4. Experimental Section
Reagents: Bis-NHS-PEG, EDC·HCl, N,N-diisopropyl ethylamine
(DIPEA), ferric chloride tetrahydrate, ferrous chloride hexahydrate,
and transferrin (Tf) were purchased from Sigma-Aldrich (St. Louis,
MO). GSH and N-hydroxysuccinimide (NHS) were procured from
Sigma-Aldrich Chemical Co. (Germany). Milli-Q water, obtained from a
Millipore water purification system (Merck Millipore, India), was used
throughout the study. All chemicals were of the analytical grade and
were used without further purification.
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Figure 9. Bright field and fluorescent images of CTCs captured from blood samples of a colon cancer patient. a) Immunocytochemistry method based
on Flurescein Isothiocyanate-labeled anti-cytokeratin (green), PE-labeled anti-CD45 (red), and DAPI (blue) nuclear staining was applied to identify and
enumerate CTCs on Fe3O4-GSH-PEG-Tf coated capillary. The florescence images were acquired in 3D capillary at different planar positions with highest
intensity. b) Bright field and fluorescent merged images of CTCs captured on 3D microchannel system in series.
Synthesis of Fe3O4-GSH Conjugate: Fe3O4 nanoparticles were
synthesized by co-precipitation of Fe2+ and Fe3+ ions using ammonia
base followed by hydrothermal ripening of nanoparticles.[21] For typical
nanoparticle functionalization reaction, 500 mg of Fe3O4 was dispersed
in 15 mL Milli-Q water and 5 mL methanol by sonication for 15 min.
400 mg of GSH was dissolved in Milli-Q water and mixed with Fe3O4
solution. The mixture was then re-sonicated for 2 h. Fe3O4-GSH was
then isolated by magnetic separation, washed with repeated cycles of
excess Milli-Q water, and dried under vacuum.
Synthesis of Fe3O4-GSH-PEG Conjugate: 120 mg of bis[2-(Nsuccinimidyl-succinylamino)ethyl]polyethylene glycol (Bis-NHS-PEG;
3 kDa) was dissolved in 6 mL of Milli-Q water and was allowed to react
with 30 mg of Fe3O4-GSH in the presence of 100 µL of 1000 ppm DIPEA
at a final solution pH of 7.8. The reaction mixture was continuously
stirred at room temperature for 24 h. Fe3O4-GSH-PEG was then isolated
by magnetic separation, washed with repeated cycles of excess Milli-Q
water, and dried under vacuum.
Synthesis of Tf-PEG-GSH-Fe3O4: 40 mg of PEG-GSH-Fe3O4 was
first gently stirred in the presence of 200 × 10−3 m EDC·HCl and
200 × 10−3 m NHS at pH ~6.0 for 15 min to activate the carboxyl groups
at room temperature. Next, 10 mg of Tf was incubated with activated

Adv. Mater. Interfaces 2017, 4, 1600934

PEG-GSH-Fe3O4 for 4 h at room temperature, then washed with Milli-Q
water, and finally dried.
Functionalization of Glass Capillary: Commercially available glass
capillaries were activated in hot (80–90 °C) piranha solution (H2O2
(30%):H2SO4) (1:3) for 2 h. The treated glass capillaries were then
rinsed thoroughly with Milli-Q water and dried under vacuum at room
temperature. Silanization of the glass capillary surface was carried out
by treating the glass with (3-aminopropyl) triethoxysilane in toluene (3%
solution) at room temperature for 24 h. The glass substrates were rinsed
with toluene and Milli-Q water, respectively, and the density of the amine
groups on the silanized glass surface was estimated by a colorimetric
assay reported by Noel et al.[22] Five different silanized substrates were
measured to estimate the average density of amine groups on the
silanized surfaces.
Anchoring Fe3O4-GSH-PEG-Tf Matrix on Silane-Functionalized
Glass Capillary: First, the carboxyl group in the GSH linker of Fe3O4GSH-PEG-Tf (10 mg) was activated in 3 mL solution of 200 × 10−3 m
EDC·HCl and 200 × 10−3 m NHS with gentle shaking for 15 min. 10 µL
of Fe3O4-GSH-PEG-Tf solution was passed through the inert part of
silanized glass capillary and the capillary was rolled for 2 min for
uniform coating. This step was repeated twice and finally the film was
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dried under vacuum at room temperature. The coated glass capillary
(NMSFGC) was then repeatedly washed with Milli-Q water to remove
any noncovalently attached material and again re-dried under vacuum at
room temperature.
Cell Culture and Patients: HCT116 cells (ATCC) were cultured in
McCoy’s cell culture medium (Invitrogen) supplemented with 10%
fetal calf serum (Invitrogen), 100 units penicillin (Invitrogen), and
100 µg mL−1 streptomycin (Invitrogen) in 25 cm2 flask. After incubation
for 4 d at 37 °C and 5% CO2, cells were trypsinized, stained with 1×
Trypan blue, and counted using Neubauer chamber. Blood from healthy
volunteer was obtained by strictly following protocols and guidelines of
the ethics committee. All cancer patient samples included in this study
were collected at Manik Hospital and Research Center, Aurangabad,
India with their informed consent. The Manik Hospital and Research
Center ethics committee approved the study and consent forms. The
conducted study strictly adhered to the approved protocols and the
guidelines of the ethics committee.
Capture of Cancer Cells in McCoy Medium: Preliminary studies revealed
that the optimal volume of the glass capillary to hold cell medium was
100 µL. This optimal condition was employed in further studies for CTC
capture and isolation from McCoy medium. 100 µL of McCoy medium
containing low concentration of HCT116 cells (25 cells mL−1) was
introduced in Tf-NMSFGC using micropipette and then rolled inside the
capillary for 5 min in order to initiate the interaction between the cells
and Fe3O4-GSH-PEG-Tf. After 5 min the sample was collected from the
capillary using micropipette and transferred to another Tf-NMSFGC and
again rolled inside it for another 5 min. This procedure was repeated
one more time. The sample was then collected in 96-well plates using
micropipette. The capillaries were rinsed with PBS at least three times
in order to remove unattached cells. The number of uncaptured cells
was counted using the Zeiss Axio Observer A1 fluorescence microscope.
Also, the capture efficiency in medium with different cell concentrations
of ≈25, 50, and 100 cells 100 µL−1 was also evaluated.
Capture of Cancer Cells from Cancer Cell-Spiked Blood Samples: 25 dual
fluorescent HCT116 cells were spiked in 100 µL of blood from healthy
person. Then the blood was lysed using RBC lysis buffer using 1:3
blood:RBC lysis buffer proportion. The sample was incubated at room
temperature on rotator at 50 rpm for 5 min, followed by centrifugation
at 2000 rpm for 3 min. The supernatant was discarded and pellet was
re-suspended in 100 µL PBS. This PBS was inserted in Tf-NMSFGC and
rolled inside the capillary for 5 min in order to initiate the artificial CTC
sample and Fe3O4-GSH-PEG-Tf interaction. After 5 min the sample was
collected from the capillary using micropipette and transferred to another
Tf-NMSFGC and rolled inside it for another 5 min. This procedure was
repeated one more time. The sample was then collected in 96-well plates
using micropipette followed by rinsing of the capillaries with PBS at least
three times. The number of uncaptured cells was counted using the Zeiss
Axio Observer A1 fluorescence microscope fluorescence microscope.
Capture of CTC Cells from Clinical Colon Cancer Patient Sample:
Peripheral blood obtained from clinically advanced cancer patients
(including colon and breast cancer patients) in the age group of
45–60 years was used for the experiment. 1 mL of the blood was lysed
in 3 mL RBC lysis buffer at room temperature for 15 min on rotator
at 50 rpm. The sample was centrifuged at 2000 rpm for 15 min at
room temperature. The supernatant was discarded and pellet was
resuspended in 500 µL PBS. This was followed by fixation of the
sample by incubating with 4% paraformaldehyde (500 µL) for 10 min
on rotator at 50 rpm. The sample was then centrifuged at 2000 rpm
for 15 min at room temperature. The supernatant was discarded and
pellet was resuspended in 300 µL PBS. Finally, the sample was stained
with anitcytokeratin18 (Abcam) and anti CD45 antibodies (Santa Cruz
Biotechnology) for 1 h at room temperature and DAPI (0.5 mg mL−1)
for 10 min at room temperature and visualized in 96-well plates under
the fluorescence microscope (Zeiss Axio Observer A1 fluorescence
microscope). After confirming that the stained/tested blood fraction
contains cancer cell, the blood was inserted in the Tf-NMSFGC flow
channel and rolled inside the capillary for 5 min in order to initiate
the blood and Fe3O4-GSH-PEG-Tf interaction. After 5 min the sample
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was collected from the capillary using micropipette and transferred to
another Tf-NMSFGC and again rolled inside it for another 5 min. This
procedure was repeated one more time. The blood sample was then
collected in 96-well plates using micropipette. The capillaries were rinsed
with PBS at least three times to get rid of unattached cells. The number
of uncaptured cells was counted using the fluorescence microscope.
Characterization: TEM analysis was performed using a Philips (CM
200) TEM machine set at an accelerating voltage of 200 kV. Samples
for TEM were prepared by placing a drop of the Fe3O4-GSH-PEG-Tf
suspension in deionized water on a Formvar-covered copper grid and
then evaporating the water at room temperature. Conjugation of protein
(Tf) to Fe3O4-GSH-PEG was confirmed by a modified Bradford assay.
Fluorescence imaging and counting of cells were performed using Zeiss
Axio Observer A1miscroscope (Carl Zeiss, Jena, Germany).

Supporting Information
Supporting Information is available from the Wiley Online Library or
from the author.
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